These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 26676219)

  • 21. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S; Musílková J; Nedoma J; Proska J; Shelkovnikov S; Vorlícek J
    Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscarinic receptor binding activity in rat tissues by vibegron and prediction of its receptor occupancy levels in the human bladder.
    Yamada S; Chimoto J; Shiho M; Okura T; Morikawa K; Kagota S; Shinozuka K
    Int J Urol; 2021 Dec; 28(12):1298-1303. PubMed ID: 34545632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of central muscarinic receptor binding activity by oxybutynin, tolterodine and darifenacin used to treat overactive bladder.
    Oki T; Kageyama A; Takagi Y; Uchida S; Yamada S
    J Urol; 2007 Feb; 177(2):766-70. PubMed ID: 17222678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive evaluation of brain muscarinic receptor occupancy of oxybutynin, darifenacin and imidafenacin in rats by positron emission tomography.
    Yoshida A; Maruyama S; Fukumoto D; Tsukada H; Ito Y; Yamada S
    Life Sci; 2010 Jul; 87(5-6):175-80. PubMed ID: 20598326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rapid determination of propiverine and its N-oxide metabolite in human plasma by high performance liquid chromatography-electrospray ionization tandem mass spectrometry.
    Yoon KH; Lee SY; Jang M; Ko SH; Kim W; Park JS; Park I; Kim HJ
    Talanta; 2005 May; 66(4):831-6. PubMed ID: 18970060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of muscarinic receptors and the m3 subtype in white-footed mice by dietary exposure to parathion.
    Jett DA; Hill EF; Fernando JC; Eldefrawi ME; Eldefrawi AT
    J Toxicol Environ Health; 1993 Jul; 39(3):395-415. PubMed ID: 8350385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
    Thomas EA; Hsu HH; Griffin MT; Hunter AL; Luong T; Ehlert FJ
    Mol Pharmacol; 1992 Apr; 41(4):718-26. PubMed ID: 1569923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Saw Palmetto Extract on Urodynamic Parameters, Bladder Muscarinic and Purinergic Receptors and Urinary Cytokines in Rats with Cyclophosphamide-Induced Cystitis.
    Nasrin S; Masuda E; Kugaya H; Osano A; Ito Y; Yamada S
    Low Urin Tract Symptoms; 2014 Jan; 6(1):57-63. PubMed ID: 26663502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
    Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of Bladder Afferent Activity by Propiverine and its Active Metabolites (M-1 and M-2) in Rats.
    Matsumoto Y; Torimoto K; Hayashi Y; Nanri M; Kiniwa M; Hirao Y; Yoshimura N
    Low Urin Tract Symptoms; 2012 Sep; 4(3):150-3. PubMed ID: 26676623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteration of muscarinic and purinergic receptors in urinary bladder of rats with cyclophosphamide-induced interstitial cystitis.
    Kageyama A; Fujino T; Taki Y; Kato Y; Nozawa Y; Ito Y; Yamada S
    Neurosci Lett; 2008 May; 436(1):81-4. PubMed ID: 18372110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of tissue integrity on pharmacological phenotypes of muscarinic acetylcholine receptors in the rat cerebral cortex.
    Md Anisuzzaman AS; Nishimune A; Yoshiki H; Uwada J; Muramatsu I
    J Pharmacol Exp Ther; 2011 Oct; 339(1):186-93. PubMed ID: 21719469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB; Eubanks JH; Creese I
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors.
    Nilvebrant L
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 1():1-45. PubMed ID: 3524114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct in vitro and in vivo demonstration of muscarinic receptor binding by the novel radioligand, [
    Yamada S; Kuraoka S; Ito Y; Kagota S; Shinozuka K; Onoue S
    J Pharmacol Sci; 2020 Mar; 142(3):127-130. PubMed ID: 31889618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selectivity of class I antiarrhythmic agents, disopyramide, pirmenol, and pentisomide for peripheral muscarinic M2 and M3 receptors.
    Endou M; Hattori Y; Gando S; Kanno M
    J Cardiovasc Pharmacol; 1992 May; 19(5):674-81. PubMed ID: 1381764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of benzodiazepine receptor, adrenoceptor and muscarinic receptor by diazepam in rat parotid gland.
    Ouchi K; Yamagishi-Wang H; Sawaki K; Watanabe M; Kawano T; Kawaguchi M
    Eur J Pharmacol; 2011 Apr; 657(1-3):20-5. PubMed ID: 21291883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological effects of propiverine and its active metabolite, M-1, on isolated human urinary bladder smooth muscle, and on bladder contraction in rats.
    Sugiyama Y; Yoshida M; Masunaga K; Satoji Y; Maeda Y; Nagata T; Inadome A; Ueda S
    Int J Urol; 2008 Jan; 15(1):76-81. PubMed ID: 18184179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.